TOPIC

HEALTHCARE SPENDING News & Analysis

Is CSL undervalued after earnings season wobble?
Stocks
Is CSL undervalued after earnings season wobble?
The ASX's biggest healthcare name saw its shares fall after reporting first-half results.
Shane Ponraj, CFA | 12 February 2025
6 stocks that let you sleep at night
Stocks
6 stocks that let you sleep at night
These wide-moat, low-uncertainty names are reliable, writes Susan Dziubinski.
Susan Dziubinski | 10 May 2021
4 retirement blind spots
Retirement
4 retirement blind spots
These common trouble spots can catch retirees off guard (who don't plan for them).
Yan Barcelo | 02 March 2021
Health sector tipped to outperform in 2021
Stocks
Health sector tipped to outperform in 2021
And Morningstar analysts say Australian names such as CSL and ResMed are set to benefit, writes Nicki Bourlioufas.
Nicki Bourlioufas | 14 December 2020
What could we expect from a Biden presidency?
Markets
What could we expect from a Biden presidency?
The Democrat's platform proposes major new spending programs, including healthcare, clean/renewable energy, infrastructure, and education, among...
David Sekera, CFA | 09 November 2020
Health companies boost portfolio immunity as recession looms
Stocks
Health companies boost portfolio immunity as recession looms
Local names are tipped to rebound as the pandemic forces a contraction in Australia’s economy.
Glenn Freeman | 03 June 2020
Opportunity knocks with Chinese shares
Stocks
Opportunity knocks with Chinese shares
China’s new economy sectors are forecast to rebound from the short-term sell-off and continue to do relatively well.
Arian Neiron | 17 February 2020
Top 10 articles of last week
Stocks
Top 10 articles of last week
An examination of the perilous state of the economy topped our coverage this week, alongside a look at opportunities in healthcare and Morningstar's...
Lex Hall | 15 July 2019
Coalition 'back in black' with election-pitch budget
Personal Finance
Coalition 'back in black' with election-pitch budget
The Coalition's budget is a blatant election pitch, trumpeting a return to surplus and rich in tax cuts, concessions for small business and...
AAP | 02 April 2019
Cochlear outlook positive but market 'overstating' profit lift
Stocks
Cochlear outlook positive but market 'overstating' profit lift
The early negative market reaction to Cochlear's half-yearly result is overdone and ignores solid growth in hearing implant upgrades, says...
Glenn Freeman | 19 February 2019